IPAMORELIN product pack
Deus Medical logo

IPAMORELIN (Growth Hormone-Releasing Peptide)

• CAS number: 170851-70-4
• Molecular Weight: 711.87 g/mol
• Formula: C38H49N9O5

Authenticity protected scan our product QR code


IPAMORELIN (Growth Hormone-Releasing Peptide)

IPAMORELIN product pack


IPAMORELIN (Growth Hormone-Releasing Peptide) is a man-made highly selective agonist of the ghrelin/growth hormone secretagogue receptor. It is used to treat children with growth hormone deficiency, adult GH deficiency, catabolic stats, and obesity. It is manufactured as a IPAMORELIN (Growth Hormone-Releasing Peptide) 2mg/vial injection which contains Growth Hormone-Releasing Peptide 2mg and excipients.

IPAMORELIN Mechanism of Action

IPAMORELIN stimulates the release of growth hormone by acting on the ghrelin/growth hormone secretagogue receptor (GHS-R). It is still unclear the exact mechanism for GH release after the GHSR is stimulated. However, studies have shown that it acts directly on the pituitary gland and the hypothalamus, as well as GHRH and somatostatin. It does not stimulate the production of cortisol, ACTH, prolactin, FSH or LH, unlike several other GH secretagogues. This makes it highly selective and efficient for the treatment of Growth Hormone deficiency. 


As directed by the physician.


Redness, itching, increased appetite, tiredness, and excess sweating.

IPAMORELIN Interactions

Insulin, testosterone, ethinylestradiol, growth hormone, IGF-1. 


? Growth Hormone-Releasing Peptide . . . 2mg
? Excipients . . . . . . . . . . . . . . . . . . . . . q.s

IPAMORELIN back of the product pack
Authenticity protected scan our product QR code


We are offering a diverse range of pharmaceutical products, which are available only from an authorized resellers. Our highly-regarded partners are comprised of industry experts who share our values and commitment. Our goal is to strengthen our network of prestigious professionals who strive to deliver great quality products.
We believe that partnerships are essential to drive change, innovation and transformation, and we are committed to ensuring the success of our collaborations.